St. John’s AI Lab Awarded Grant to Study Drug Repurposing
July 27, 2026An artificial intelligence (AI) research lab housed in The Lesley H. Collins College of Professional Studies at St. John’s University has been awarded more than $500,000 from the National Institutes of Health (NIH) to advance an effort focused on drug repurposing.
July 27, 2026An artificial intelligence (AI) research lab housed in The Lesley H. Collins College of Professional Studies at St.
The initiative, called RESPOND: Repurposing Drugs for Respiratory Disorders Using a Hybrid Neuro-Symbolic AI Approach, will combine machine learning with biomedical knowledge to help researchers examine relationships among drugs, diseases, genes, biological pathways, and other forms of evidence. The project will also examine how.
What Happened
Bukhari, developing an entirely new medicine can require years of laboratory research, clinical testing, regulatory review, and substantial financial investment. Alternatively, drug repurposing examines whether medicines that have already been developed and approved for one condition might be useful for treating another.
John’s University has been awarded more than $500,000 from the National Institutes of Health (NIH) to advance an effort focused on drug repurposing.
The NIH grant will be distributed annually from July 2026 to June 2029, Dr.
In 2024, the lab received a $550,000 grant from the US National Science Foundation to develop an AI solution for the time-consuming process of medical coding and health care billing.
Key Details
A class of drugs known as GLP-1 receptor agonists, for example, was initially developed for the treatment of Type 2 diabetes. Researchers later found that several of these medicines could produce weight loss, leading to their use as treatments for obesity and.
Holmes, Ph.D., Associate Dean for Innovation and Partnership [email protected] ( QUEENS, NY, July 8, 2026) — The School of Education at St.
John’s University’s annual Great Lawn Summer Concert struck a new chord on June 30 when, for the first time in its 26-year history, the performance was headlined by an alumnus.
John’s University students showcased their entrepreneurial spirit on July 2 when the Venture & Innovation Center (VIC) hosted its annual Startup BootCamp demo day.
Why It Matters
AI can serve as a support tool in similar research, helping to narrow an extremely large pharmaceutical search space into a focused set of drug candidates that researchers can then evaluate. During that time, his team of machine-learning engineers and St.
It also reflects the increasing role of data technology in helping researchers address difficult health challenges, Dr.
AI can help scientists navigate biomedical knowledge and identify treatment opportunities that might otherwise remain undiscovered.
What Reports Say
Coverage of the story so far points to:
Continued reporting by St. John's University as more details emerge
